- Regen-CoV is the brand name of a combination of two antibodies that attack SARS-CoV-2. The antibodies are as follows:
- AT-527 is a nucleoside analogue that is being developed as a potential treatment for COVID-19. The drug is taken orally. This drug is an analogue of a naturally occurring substance called guanosine.…
- Adenoviruses are a large family of viruses that can cause a range of illness in people and animals. In people, these viruses can cause relatively mild illness such as colds and pink eye or more…
- Clinical trials of the Janssen COVID-19 vaccine (in some parts of the world this is called the Johnson & Johnson COVID-19 vaccine) have found that it is generally safe.
- Most people infected with SARS-CoV-2 have mild symptoms or none at all. However, a minority of people can develop severe symptoms, including difficulty breathing and pneumonia, and require…
- Researchers at Sheffield Hallam University in Sheffield, England, recruited people for interviews who were experiencing long COVID. Using a database and an algorithm, researchers randomly selected a…
- Although many people hospitalized with acute COVID-19 have died, many have also survived. After their recovery from acute COVID-19, some people have persistent symptoms. Researchers have recently…
- Many people who developed serious complications of COVID-19 were hospitalized. Some of the people who survived have gone on to develop long-term complications (called long COVID).
- Researchers at the University of California at San Diego (UCSD) surveyed more than 300 HIV-positive people about their overall health, behaviours and activity, ...
- According to Mark Mattson, PhD, chief of the Laboratory of Neurosciences at the National Institute on Aging in Bethesda, Maryland, research on animals and with ...
- Experiments with animals and people have found that as they age the brain slowly degrades. Specifically, the perception of senses, memory and thinking abilities ...
- Researchers in Toronto and Calgary, led by University of Toronto neuroscience professor Sean Rourke, PhD, have been studying how HIV affects the brain and ...